The Eleventh Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on Saturday with calls to member states to take stronger action on reducing the environmental harm of tobacco use and increasing corporate liability. But political stand-offs between countries, along with industry interference, hindered major breakthroughs on […] Continue reading ->
The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates.  A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading ->
The first pregnant woman infected with malaria has been recruited into a Phase 3 trial in Mali that is evaluating the efficacy and safety of antimalarial drugs during the first trimester of pregnancy. Pregnant women are more susceptible to malaria as they have reduced immunity, and malaria poses serious risks to both mothers and babies. […] Continue reading ->
(The New Humanitarian) The International Rescue Committee, one of the oldest humanitarian aid organizations in the United States, is cutting thousands of staff, in another sign of the turmoil rippling across the humanitarian sector as the US aid funding freeze continues. “We have had to take immediate and significant cost-cutting measures, including laying off and furloughing […] Continue reading ->